NY stem cell research nears dangerous line
By Jesse Reynolds,
Newsday
| 01. 23. 2009
Stem cell research may soon make headlines again. The restrictions on federal funding imposed by former President George W. Bush are expected to be lifted. But here in New York, a different type of stem cell controversy is brewing.
Since 2007, the state has managed a large stem cell research funding program of its own, second only to that of California. While it has quietly been issuing millions of dollars in grants for a wide range of work, the program is considering crossing an unprecedented - and dangerous - ethical line.
Most of the debates around stem cell research have focused on the use of embryos left over in fertility clinics. Hopeful parents undergoing assisted reproduction often end up with more embryos than they need, and these could be used in medical research. Bush's policy limited federal funding for this line of work; President Barack Obama is expected to lift that restriction very soon.
The issue in New York is different. If stem cells could be derived from embryos made using cloning techniques, they would have all the genes of...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
